Life Science Investing

The Medicines Company Reports Q3 Financial Results

Biotech Investing

Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East

Cannabis Investing News

RAMM Pharma Corp. Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.

Cannabis Investing News

Lexaria Equity Financing and Corporate Strategy Update

Cannabis Investing News

Surmodics Notches Breakthrough Device Designation from FDA

Medical Device Investing

RAMM Pharma Corp. (formerly MTC Growth Fund-I Inc.) Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.; Trading Anticipated to Commence November 8, 2019

Cannabis Investing News

Novus Therapeutics Receives FDA Guidance for Phase 2a POP201 Study

Pharmaceutical Investing

Artelo Biosciences Selects Research Organization for Phase 1b/2a Study

Biotech Investing

Navidea Biopharmaceuticals Announces Positive Phase 2B Study Results

Biotech Investing

LexaGene Announces Closing of C$6.6 Million Financing

Biotech Investing

PreveCeutical Announces Successful Completion from its Design, Synthesis and Preliminary Evaluation of Novel Designed Peptides Derived from Caribbean Blue Scorpion Venom in a Cell-Based Brain Cancer Model

Biotech Investing

Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia

Biotech Investing

Latest life science News

More life science News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×